[Nasopharyngeal angiofibroma with intracranial extension: situating the chemotherapy-radiotherapy association].
Nasopharyngeal angiofibroma is a locally aggressive, although histologically benign, vascular neoplasm. This neoplasm accounts for 0.05% of head and neck tumours and affects almost exclusively male adolescents. Surgery is considered as the primary treatment of nasopharyngeal angiofibroma. Other treatment modalities such as radiotherapy and chemotherapy are still recommended for intracranial extension involving the cavernous sinus or the internal carotid artery. We report a rare case of nasopharyngeal angiofibroma, further complicated with a Kennedy syndrome in a 34 year-old women. The treatment consisted in a chemotherapy (adriamycine, decarbazine) followed by radiotherapy. We discuss the relevance and outcome of the association chemotherapy-radiotherapy in the treatment of nasopharyngeal angiofibromas with a consistent intracranial extension (stage III B of Arch Otolaryngol Head Neck Surg 122 (2003) 122-129).
Belcadhi
M
M
Service d'ORL et de chirurgie cervicofaciale, CHU Farhat-Hached de Sousse, avenue Ibn-El-Jazzar, 4000 Sousse, Tunisie.
Mani
R
R
Harzallah
M
M
Bouaouina
N
N
Bouzouita
K
K
D000328:Adult; D018322:Angiofibroma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D001932:Brain Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D009361:Neoplasm Invasiveness